D’autres conférences présentées par EOCI :

Archived Presentations

ACCREDITED SYMPOSIA
Lunch Symposium: Time to treatment in HF: The time is now
Jonathan Howlett, MD (Chair) - Martin Cowie, MD - Nadia Giannetti, MD - Peter Liu, MD
Breakfast Symposium: Questions about Diabetes and HF you were too afraid to ask
Shelley Zieroth, MD (Chair) - Vineeta Ahooja, MD - Kim Connelly, MBBS, PhD - Elizabeth Swiggum, MD - Subodh Verma, MD, PhD
Lunch Symposium: Interrupting the pathway of heart failure
Jonathan Howlett, MD (Chair) - John McMurray, MD - Sean Virani, MD - Karen Harkness, RN, PhD
JOINT PLENARY: PRECISION MEDICINE: PATIENT, POPULATION, OR BOTH?
Can macrodata predict response to therapy?
Larry Allen, MD
Genes to genomes: Evolution of molecular testing for inherited cardiomyopathy
Birgit Funke, PhD
The journey of the biomarker from bench to bedside
Douglas Lee, MD
CHFS CLINICAL WORKSHOPS I
CCS comprehensive HF guidelines
Michael McDonald, MD - Eileen O'Meara, MD
Ms. Understood: Gender-based differences and HF therapies: Drugs, devices and surgery
Vivek Rao, MD - Shelley Zieroth, MD
What patient advocacy means in 2018
Jillianne Code, PhD - Sean Virani, MD
JOINT PLENARY: EVOLVING CONCEPTS IN HEART FAILURE
Amlodipine therapy for iron-overload cardiomyopathy: The enduring value of translational research
Gavin Oudit, MD
Heart failure with and without atrial fibrillation: Are they different diseases?
Martin Cowie, MD
CHFS CLINICAL WORKSHOPS II
Bridging the gap between clinical medicine and basic science: Opening Pandora's box
Phyllis Billia, MD - Anthony Gramolini, PhD
Nursing: Managing goals of care
Leah Steinberg, MD - Pat Strachan, RN, PhD
Cardiorenal disease
Nadia Giannetti, MD
TED ROGERS CENTRE SCIENTIFIC SESSION: CARDIAC SIGNALLING & METABOLISM
HDL and cell signalling in the heart: Roles in cardioprotection
Bernardo Trigatti, PhD
JOINT PLENARY: SWEET FAILURE: HFpEF AND DIABETES
Targeting the diagnosis of HFpEF
Justin Ezekowitz, MB BCh
New and emerging heart failure therapies: 2018 and beyond
John McMurray, MD
Diabetic cardiomyopathy: Real or imagined?
Kim Connelly, MBBS, PhD
CHFS CLINICAL WORKSHOPS III
Nursing: Initiation & titration of HF medications
Karen Harkness, RN, PhD - Serge Lepage, MD
Advanced HF therapies: When to refer patients
Stephanie Poon, MD
Imaging tools for HF in 2018
Carolina Alba, MD - Nowell Fine, MD
TED ROGERS CENTRE SCIENTIFIC SESSION: THE IMPORTANCE OF GENOMICS TO OUR UNDERSTANDING OF HEART DISEASE
Genomic-guided therapies: Can we cure cardiomyopathy?
Carolyn Ho, MD
A novel biomarker for arrhythmogenic cardiomyopathy
Robert Hamilton, MD
JOINT PLENARY: WHAT WE MUST KNOW ABOUT CARDIOTOXICITY
Why cardiologists must care about cancer immunotherapy
Javid Moslehi, MD
Clonal hematopoiesis: A pathway to cancer, a pathway to heart disease
Aaron Schimmer, MD
JOINT PLENARY: ADVANCED HF PART I: EARLY RECOGNITION, PREVENTION AND REFERRAL
What is advanced heart failure and is it on the rise?
Mandeep Mehra, MD
How can we help people with diabetes prevent chronic and acute heart failure?
Michel Komajda, MD
CHFS CLINICAL WORKSHOPS I
Managing HFpEF
Sean Virani, MD
CCS heart failure guidelines reload
Kim Connelly, MBBS, PhD - Serge Lepage, MD - Elizabeth Swiggum, MD
The who, what, why & how of advocacy for heart failure patients
Jillianne Code, PhD
JOINT PLENARY: ADVANCED HF PART II: INTERVENTIONS & RECOVERY
Down the rabbit hole of mechanical circulatory support
Mitesh Badiwala, MD, PhD
Recovery – from the myocardium to patient quality of life
Josef Stehlik, MD
Heart failure and atrial fibrillation: chicken or egg?
Justin Ezekowitz, MB BCh
CHFS CLINICAL WORKSHOPS II
Goals of care and advanced heart failure symptom management
Catherine Demers, MD
E-health: taking advantage of technology
Joseph Cafazzo, PhD - Nadia Thomson, NP
How to use biomarkers for your heart failure patients
Gordon Moe, MD
CHFS PLENARY: THE MANY CONSIDERATIONS OF COMPLEX HF CARE
HFpEF: Mythbuster
Scott Solomon, MD
Managing heart failure patients with renal disease and anemia
Eileen O’Meara, MD
Clips, sparks and implantable monitors for heart failure
Anique Ducharme, MD
CHFS CLINICAL WORKSHOPS III
Is this recovered heart failure?
Jonathan Howlett, MD - Josef Stehlik, MD
Unusual and interesting heart failure cases
Carolina Alba, MD - Karen Harkness, RN, PhD
Expanding knowledge and awareness in time for the oncoming HF tsunami
Stephanie Poon, MD - Shelley Zieroth, MD
CHFS PLENARY: RIGHT HEART FAILURE
Imaging of the right ventricle
Nowell Fine, MD
When should you operate on the right ventricle?
Vivek Rao, MD, PhD
DEBATES
Be it resolved that all patients with heart failure and atrial fibrillation should be cardioverted at least once
Hisham Dokainish, MD vs Anil Gupta, MD
Friday, June 3, 2016
8:35 - 8:55 Should We Aim for a BP Target for Our HF Patients? George Honos, MD
8:55 - 9:15 How Should We Treat Beta Blocker Resistance? Martin Cowie, MD
9:15 - 9:35 Is There Still a Role for ACEs & ARBs in Systolic Heart Failure? Normand Racine, MD
9:35 - 9:55 Precision Cardiovascular Medicine Jean-Claude Tardif, MD
10:30 - 11:30
WORKSHOPS  
• CCS Guidelines to Practice: Translate, Titrate and Treat Justin Ezekowitz, MBBCh
Michael McDonald, MD
• HFpEF, LVH or Restrictive CM: How to Tell Them Apart Serge Lepage, MD
Gavin Oudit, MD
• Nursing Care for HF Patients: Case Studies (in French) Sonia Heppel, NP
Kim Laflamme, NP
11:30 - 1:00 CHFS Lunch Symposium - Implementation of Novel Heart Failure Treatments: What Works? Co-Chairs: Jonathan Howlett, MD
G.B. John Mancini, MD

Martin Cowie, MD
Nadia Giannetti, MD
Serge Lepage, MD
1:15 - 1:35 Worsening HF: Is It Really So Bad? Gordon Moe, MD
1:35 - 1:55 Which HF Patients with Atrial Fibrillation Need Rhythm Control? Laurent Macle, MD
1:55 - 2:15 Sleep-Disordered Breathing in HF: Current and Future Treatment Status John Floras, MD
2:15 - 2:35 Do Cardiologists Now Need to Treat Diabetes? Kim A. Connelly, MD
3:15 - 4:15
WORKSHOPS  
• What the General Cardiologist Should Know About LVAD Care Nadia Giannetti, MD
• Case-Based Approach to Treatment of Diabetes and Hypertension When HF Is Present (in French) Jean-Marie Ekoé, MD
• The Who, Why and How of Advocacy for HF Patients François Tournoux, MD
Saturday, June 4, 2016
8:35 - 8:55 Should We Even Benchmark Hospital Readmissions? Justin Ezekowitz, MBBCh
8:55 - 9:15 Learnings on Prevention of Rehospitalization: What Works and What Doesn't? Peter Liu, MD
9:15 - 9:55 What Would You Have Done Differently:
Cases on Readmissions and How to Prevent Them
Michael Chan, MD
Anique Ducharme, MD
Karen Harkness, NP, PhD
Shelly Zieroth, MD
10:30 - 11:30
WORKSHOPS  
• Nursing Certification and Managing Hospital-to-Home Transition Nancy Albert, PhD
• CANCARE-CCTN Workshop: Right Ventricular Dysfunction in Critically Ill HF Patients Rakesh Arora, MD
Patrick Bellemare, MD
Yoan Lamarche, MD
Michael McDonald, MD
• CCS Guidelines to Practice: Translate, Titrate and Treat (in French) Anique Ducharme, MD
Eileen O'Meara, MD
1:15 - 1:35 Tailoring the Echocardiographic Exam for Consideration of Percutaneous Valve Therapies Wendy Tsang, MD
1:35 - 1:55 Heart Failure with Preserved Ejection Fraction: A Misunderstood Disease in Search of a Therapy Scott Solomon, MD
1:55 - 2:35 LVAD, Transplant or Medications, or Palliation: Cases with the Experts Haissam Haddad, MD
Michael McDonald, MD
Mustafa Toma, MD